EWTX — Edgewise Therapeutics Inc. price, chart and key statistics

Price data

Price

$39.75

YTD price return

+60.19%

YTD total return

+60.19%

Next earnings

Nov 5, 2026

Market cap

4.3B2021-03 1.6B2026-10 4.3B+169.7% over the window

Enterprise value

4.2B

Shares outstanding

108.6M2020-12 1M2026-06 108.6M+10658.4% over the window

52W low

$14.68

52W high

$48.51

From 52W high

-18.06%

From 52W low

+170.87%

52W range

74%

Volume

Rel volume

1.15×

30D volume

1.7M

30D $ vol

68M

Fundamentals

EPS (ttm)

-$1.852020-12 -$23.172026-06 -$1.85-92.0% over the window

FCF (ttm)

-158.8M2020-12 -14.8M2026-06 -158.8M+970.5% over the window

FCF/share

-$1.462020-12 -$14.702026-06 -$1.46-90.0% over the window

Book value/share

$4.132020-12 -$33.112026-06 $4.13-112.5% over the window

ROE

-44.02%2021-12 -15.6%2026-06 -44.0%+182.1% over the window

ROA

-41.11%2020-12 -13.1%2026-06 -41.1%+214.9% over the window

Current ratio

16.242020-12 29.862026-06 16.24-45.6% over the window

Growth (CAGR, ttm) · 10Y

Shares

+3.10%2025-06-30 → 2026-06-30105.3M → 108.6M (+3.1% total)+19.61%2023-06-30 → 2026-06-3063.5M → 108.6M (+71.1% total)+17.13%2021-06-30 → 2026-06-3049.3M → 108.6M (+120.5% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Book value/share

-26.23%2025-06-30 → 2026-06-30$5.59 → $4.13 (-26.2% total)-5.62%2023-06-30 → 2026-06-30$4.91 → $4.13 (-15.9% total)-7.29%2021-06-30 → 2026-06-30$6.02 → $4.13 (-31.5% total)n/a

Price

+158.45%2025-10-20 → 2026-10-20$15.39 → $39.75 (+158.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+79.85%2023-10-20 → 2026-10-20$6.83 → $39.75 (+482.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+18.26%2021-10-20 → 2026-10-20$17.19 → $39.75 (+131.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+158.45%2025-10-20 → 2026-10-20$15.39 → $39.75 (+158.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+79.85%2023-10-20 → 2026-10-20$6.83 → $39.75 (+482.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+18.26%2021-10-20 → 2026-10-20$17.19 → $39.75 (+131.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-21.5×2021-03 -93.492026-10 -21.89-76.6% over the window

Fwd P/E

-21.0×

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

9.6×2021-03 5.222026-10 9.63+84.4% over the window

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-3.68%2020-12 -0.9%2026-06 -3.6%+288.4% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 108.6M ÷ 105.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-3.10%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-3.10%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.4B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-3.10%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($4.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2020-12 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($4.3B). Same caveat as the cash buyback yield.

0.00%2020-12 0.0%2026-06 0.0%

Vs own 10Y history

P/B

96th